This inventor holds 1 USPTO granted patent. Top assignee: Research Corporation Technologies, Inc.. Active years: 1993.
Company Filing History:
Years Active: 1993
Title: Jisong Li: Innovator in Androgen Synthesis
Introduction
Jisong Li is a prominent inventor based in Baltimore, MD (US). He has made significant contributions to the field of biochemistry, particularly in the area of androgen synthesis. His innovative work has led to the development of novel compounds that have potential therapeutic applications.
Latest Patents
Jisong Li holds a patent for "20-substituted pregnene derivatives and their use as androgen synthesis." This patent describes novel 20-substituted-pregnene derivatives, compositions containing such derivatives, and methods for their use and manufacture. The 20-substituted-pregnene derivatives inhibit the androgen biosynthesis enzymes 17(alpha)-hydroxylase/C.sub.17,20-lyase and 5(alpha)-reductase. Therefore, these compounds are useful for reducing or inhibiting the production of androgens where they have an adverse role in a disease or physiological condition in vertebrate species. He has 1 patent to his name.
Career Highlights
Jisong Li is currently associated with Research Corporation Technologies, Inc., where he continues to explore innovative solutions in his field. His work has garnered attention for its potential impact on health and disease management.
Collaborations
One of his notable collaborators is Angela Brodie, with whom he has worked on various projects related to androgen synthesis and its implications in medical science.
Conclusion
Jisong Li's contributions to the field of androgen synthesis through his innovative patents highlight his role as a key inventor in biochemistry. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.